We sum up the latest developments in one of the industry's hottest fields
There have been multiple recent announcements across the world about investments in cleaner forms of hydrogen. These mainly refer to ‘green hydrogen’ produced by electrolysis, though also ‘blue hydrogen’, which is made from natural gas in a reforming process, in which CO2 emissions are captured for storage.
Ascensus has completed the acquisition of Strem Chemicals, bringing together two major suppliers of catalogue chemicals, mainly for life science, microelectronic and other speciality applications. Strem CEO Ephraim Honig will become chief science and innovation officer and will oversee the combined businesses’ R&D function.
Croda International has come first in the Most Sustainable International Company rankings for companies headquartered outside the US. Calvert Research and Management, a responsible investment management firm, carried these rankings out for financial news source Barron’s. It analysed more than 230 key performance indicators of environmental, social and governance performance.
In a pre-close trading update for the financial year ended 31 March 2021, Johnson Matthey (JM) CEO Robert MacLeod revealed that: “We have commenced a strategic review of Health, as we continue to focus resources to maximise value for our shareholders”.
Full results will be announced on 27 May but it is known that Health, which offers API custom manufacturing services, controlled substances, catalysts and generics, generated sales of £223 million, about 5% of the total sale. The division’s full-year operating performance is expected to be above the prior year.
China’s State-owned Assets Supervision & Administration Commission (SASAC) has approved the long-planned merger of Sinochem and ChemChina. Partly to alleviate competition concerns, they will operate as separate subsidies of a newly created holding company owned by SASAC.
The combined entity will be by far the largest chemical producer in the world, with assets of about $245 billion. “This joint restructuring will create synergy, build up a world-class chemical company and promote a high-quality development of the chemical industry in China,” Sinochem said.
DSM has agreed to acquire the biobased flavour and fragrance (F&F) intermediates business of synthetic biotechnology company Amyris. This comprises seven products, of which four are “already generating meaningful sales”, two newly launched and one under development. They will be added to the DSM’s Personal Care & Aroma Ingredients activities, extending its offer to the F&F and cosmetics industries.
German CDMO KD Pharma, which is one of the world’s largest producers of omega-3 fatty acids has acquired the assets of former CDMO RohnerChem at Pratteln, near Basel, Switzerland (pictured), and hired some of the former team. Terms were not disclosed.
KD said that it aims to become an even bigger player and that the site’s “unique chemical processes and technological capabilities” enabled it “to manufacture difficult, multi-step pharmaceutical intermediates and APIs. This is a natural fit with our strategy.”
